Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Alison
Alison Amenta, Pawtucket, RI US
| Patent application number | Description | Published |
|---|---|---|
| 20100130405 | BIGLYCAN AND RELATED THERAPEUTICS AND METHODS OF USE - The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders. | 05-27-2010 |
| 20110053854 | TREATMENT OF MUSCULAR DYSTROPHIES AND RELATED DISORDERS - The invention provides, among other aspects, compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; diseases or conditions associated with an abnormal level or activity of collagen VI; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); and disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. | 03-03-2011 |
| 20110183910 | BIGLYCAN AND RELATED THERAPEUTICS AND METHODS OF USE - The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders. | 07-28-2011 |
Alison Axe, Surrey GB
| Patent application number | Description | Published |
|---|---|---|
| 20120039820 | ANTIBACTERIAL COMPOSITION COMPRISING 4-ISOPROPYL-3-METHYLPHENOL AND ZINC IONS - A composition such as an oral care composition comprising an antibacterial system comprising 4-isopropyl-3-methyl phenol (IPMP), a source of zinc ions and an anionic surface active agent is described. | 02-16-2012 |
Alison Boncha, Rochester, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110090367 | CAMERA FOR DISPLAYING DIGITAL IMAGES - A camera includes memory for storing one or more stored images each with at least a day and month of capture; a processor which, based on the stored images, determines which day and month at least an image was captured; and a display that displays only the day and month on which at least an image was captured along with a visual indicator of whether a plurality of images was captured on the displayed day and month. | 04-21-2011 |
| 20110093775 | METHOD FOR DISPLAYING DIGITAL IMAGES - A method for presenting images to a user on a display, the method comprising the steps of providing one or more stored images each with at least a day and month of capture; based on the stored images, determining which day and month at least an image was captured; and displaying only the day and month on which at least an image was captured; and a visual indicator of whether a plurality of images was captured on the displayed day and month. | 04-21-2011 |
| 20110205397 | PORTABLE IMAGING DEVICE HAVING DISPLAY WITH IMPROVED VISIBILITY UNDER ADVERSE CONDITIONS - A digital image capture device having a soft-copy display with improved image visibility under adverse viewing conditions, comprising: an image sensor; an optical system; a soft-copy display; a data storage system storing a plurality of color transforms; an environmental sensing means; and a processor for performing the steps of capturing an input digital image; selecting a preview color transform responsive to a signal from the environmental sensing means, wherein a preview color transform that provides improved image visibility is selected for signals from the environmental sensing means corresponding to adverse viewing conditions; transforming the input digital image using the preview color transform to form a preview image; displaying the preview image on the soft-copy display; and recording the input digital image in a processor-accessible memory without using the preview color transform | 08-25-2011 |
Alison Brustein, Los Angeles, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090256042 | TABLE EDGE SUPPORTING APPARATUS - An apparatus for support a handbag from the edge of a table or other structure is presented. The apparatus includes a segmented arm that can be collapsed to allow for compact storage of the apparatus. | 10-15-2009 |
Alison Chaltas, Stamford, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100044326 | METHOD AND APPARATUS FOR DISPLAYING AND SELLING PRODUCTS - A method and apparatus for displaying and selling products from different product segments within a planogram for products of only one product segment. A product display interrupter is provided in a product display of products from a single product segment to interrupt the display to draw the consumer's attention to another product not of that product segment. The product display interrupter may be in the form of a stand-alone display structure. Preferably, the products to be displayed are framed by and within the product display interrupter. Indicia, such as information on how the products are to be used in conjunction with one another, may be provided on the product display interrupter. | 02-25-2010 |
Alison Clark, Earley GB
| Patent application number | Description | Published |
|---|---|---|
| 20100017238 | TRAVEL MANAGEMENT SYSTEM - A travel management system. In one implementation, a state-based desktop client provides a travel planning and management workspace for the user. The user may perform travel planning activities, and log out of the travel workspace without having to repeat travel planning tasks. In another implementation, travel planning tasks may be stored as data feeds that keep up-to-date fare and availability data even when the user is not logged into the travel workspace. | 01-21-2010 |
| 20100017314 | TRAVEL EXPENSE MANAGEMENT SYSTEM - A method for generating an expense report, comprising: receiving an itinerary for travel, generating a description and a cost for one or more travel elements of the itinerary; and generating projected expenses that are expected to be incurred based on historical data associated with the itinerary | 01-21-2010 |
Alison Crumblehulme, Burlington CA
| Patent application number | Description | Published |
|---|---|---|
| 20110301289 | STABILIZED DRIER FOR ALKYD-BASED COMPOSITIONS - The present invention relates to a stabilized drying catalyst (‘drier’) for enhancing or accelerating oxidative air-drying of an alkyd-based composition, comprising an inclusion complex of a cyclodextrin and a metal salt of formula (M | 12-08-2011 |
Alison Fogarty, St. Kilda AU
| Patent application number | Description | Published |
|---|---|---|
| 20100305859 | PORTABLE ENVIRONMENTAL MONITORING INSTRUMENT - A portable environmental monitoring instrument comprising: a housing comprising a main body and a cap; a display mounted to the housing; a processing circuit disposed within the main body, the processing circuit electrically connected to the display; a light sensor mounted to the housing and electrically connected to the processing circuit; a humidity sensor electrically connected to the processing circuit; and a probe member extending from the main body and exposed to the environment by opening the cap, the probe member carrying a temperature sensor at a distal end thereof and part of an electrical connection between the temperature sensor and the processing circuit, the processing circuit arranged to process signals received from the light sensor, the humidity sensor and the temperature sensor to obtain an environmental measure indicative of the affect of the environment and control the display to display data indicative of the environmental measure. | 12-02-2010 |
Alison Goate, St. Louis, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20110177509 | RISK FACTORS AND A THERAPEUTIC TARGET FOR NEURODEGENERATIVE DISORDERS - Compositions and methods for detecting a neurodegenerative disorder, and methods of treating a neurogenerative disorder are disclosed. Biomarkers for a neurodegenerative disorder containing a polymorphism in the nucleotide sequence of PP3R1, GSK3beta, PPP3CA, FYN, WISP1, MGEA5, CTSD, F2, MAPT, OGT or PRKCA are also disclosed. A method for detecting a neurodegenerative disorder by detecting polymorphisms in the above genes is further disclosed. | 07-21-2011 |
Alison Julson, Ramsey, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110160840 | Repetitive Cell Bifurcation / Side Branch Ostia Support Stent - A stent comprises at least one closed pathway that defines a single cell. In some embodiments, the closed pathway includes a plurality of petals constructed and arranged to extend away from the tubular wall of the stent. In one embodiment, some of the petals of the closed pathway overlap other of the petals of the closed pathway when the stent is in a reduced state. In at least one embodiment, the stent comprises a plurality of closed pathways. In one embodiment, the closed pathways are arranged in bands that extend either along the length of the stent or about the circumference of the stent. | 06-30-2011 |
| 20110160843 | High Strength Low Opening Pressure Stent Design - A stent has a plurality of expansion columns that extend in a radial direction to form a circumference of the stent and interconnected in the axial direction to form an overall axial length of the stent. Each expansion column has a plurality of first cells and a plurality of second cells that alternates along the expansion column with at least one first cell. Each first cell has at least two facing walls extending in the radial direction that have a first width. The second cells each have at least two facing walls that extend in the radial direction which have a second with greater than the first width. The first cell uses less force to open than the second cell, but upon opening provides increased radial strength by creating a substantially vertical cell wall. | 06-30-2011 |
Alison Lee, Piscataway, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100112543 | PROCESSING SOFT TISSUE, METHODS AND COMPOSITIONS RELATED THERETO - In certain embodiments, the present invention relates to a process for preparing skin removed from a human donor, including a living human donor, and removing cellular components and forming a decellular matrix having as major components collagens and elastins while disinfecting the tissue. In other embodiments, the present invention relates to a process for treating a decellularized soft tissue by freezing the same at a plurality of decreasing temperatures at atmosphere or higher such that there is formation of ice crystals having a size greater than 2.0 and lyophilizing the soft tissue under vacuum to remove the water to less than 6% forming a porous matrix. | 05-06-2010 |
Alison Murphy, Milpitas, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090054475 | HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS - Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active. | 02-26-2009 |
| 20090137590 | N-LINKED HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS - Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. | 05-28-2009 |
| 20100087465 | HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS - Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active. | 04-08-2010 |
| 20100130511 | HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS - Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active. | 05-27-2010 |
Alison Rinderspacher, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110071124 | Compounds that Inhibit Production of sAPPB and AB and Uses Thereof - The present invention relates to compounds with activity as inhibitors of sAPPβ and Aβ production, and methods for treating, preventing, or ameliorating neurodegenerative diseases, such as Alzheimer's disease and pharmaceutical compositions containing such candidate compounds. | 03-24-2011 |
Alison Robeck, Monticello, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110129923 | CELL CULTURE METHODS AND DEVICES UTILIZING GAS PERMEABLE MATERIALS - Gas permeable devices and methods are disclosed for cell culture, including cell culture devices and methods that contain medium at heights, and certain gas permeable surface area to medium volume ratios. These devices and methods allow improvements in cell culture efficiency and scale up efficiency. | 06-02-2011 |
| 20110287542 | CELL CULTURE METHODS AND DEVICES UTILIZING GAS PERMEABLE MATERIALS - Gas permeable devices and methods are disclosed for cell culture, including cell culture devices and methods that contain medium at heights, and certain gas permeable surface area to medium volume ratios. These devices and methods allow improvements in cell culture efficiency and scale up efficiency. | 11-24-2011 |
| 20110287543 | CELL CULTURE METHODS AND DEVICES UTILIZING GAS PERMEABLE MATERIALS - Gas permeable devices and methods are disclosed for cell culture, including cell culture devices and methods that contain medium at heights, and certain gas permeable surface area to medium volume ratios. These devices and methods allow improvements in cell culture efficiency and scale up efficiency. | 11-24-2011 |
Alison Robeck, St. Michael, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110212519 | COMPARTMENTALIZED DEVICE FOR CELL CULTURE, CELL PROCESSING AND SAMPLE DIALYSIS - A versatile compartmentalized cell culture device, with a selectively permeable membrane separating the compartments, provides many attributes relative to traditional devices. It can be configured for high-density cell culture, co-culture, and sample dialysis while rolling or standing still. It can also be configured for continuous movement of liquid between compartments. The wide combination of attributes not found in other membrane based cell culture and bioprocessing devices includes more cell capacity, more cell secreted product capacity, higher cell and product density, increased medium capacity, minimized use of exogenous growth factors, compatibility with standard cell culture equipment and protocols, increased scale up efficiency, capacity to function when rolling or standing still, capacity for perfusion without the need for pumps, and more efficient sample dialysis. | 09-01-2011 |
Alison Sismey-Ragatz, Cassville, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20120108802 | PRODUCTION OF DEFINED MONODISPERSE HEPAROSAN POLYMERS AND UNNATURAL POLYMERS WITH POLYSACCHARIDE SYNTHASES - A methodology for polymer grafting by a polysaccharide synthase allows the creation of a variety of glycosaminoglycan oligosaccharides that have a natural, chimeric, hybrid and/or unnatural sugar structure and/or a targeted size (i.e., substantially monodisperse in size). | 05-03-2012 |
Alison Stewart, Christchurch NZ
| Patent application number | Description | Published |
|---|---|---|
| 20110009260 | METHODS AND COMPOSITIONS COMPRISING TRICHODERMA ATROVIRIDE FOR THE BIOLOGICAL CONTROL OF SOIL BORNE PLANT PATHOGENS AND PROMOTING PLANT GROWTH - The present invention relates to | 01-13-2011 |